PubMed · 15083479
Bayesian inference for randomized clinical trials with treatment failures.
Abstract
During the course of a clinical trial, subjects may experience treatment failure. For ethical reasons, it is necessary to administer emergency or rescue medications for such subjects. However, the rescue medications may bias the set of response measurements. This bias is of particular concern if a subject has been randomized to the control group, and the rescue medications improve the subject's condition. The standard approach to analysing data from a clinical trial is to perform an intent-to-treat (ITT) analysis, wherein the data are analysed according to treatment randomization. Supplementary analyses may be performed in addition to the ITT analysis to account for the effect of treatment failures and rescue medications. A Bayesian, counterfactual approach, which uses the data augmentation (DA) algorithm, is proposed for supplemental analysis. A simulation study is conducted to compare the operating characteristics of this procedure with a likelihood-based, counterfactual approach based on the EM algorithm. An example from the Asthma Clinical Research Network (ACRN) is used to illustrate the Bayesian procedure.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Michele L Shaffer, Vernon M Chinchilli. 2004-04-30. Bayesian inference for randomized clinical trials with treatment failures.. https://doi.org/10.1002/sim.1726
Cite the original work for its findings. Save a collection to share your selection of sources.